首页|全身免疫炎症指数对急性ST段抬高型心肌梗死患者PCI术后无复流的预测价值

全身免疫炎症指数对急性ST段抬高型心肌梗死患者PCI术后无复流的预测价值

扫码查看
[目的]探讨全身免疫-炎症指数(SII)对行经皮冠状动脉介入术(PCI)治疗的急性 ST段抬高型心肌梗死(STEMI)患者术后无复流的预测价值.[方法]回顾性分析 2016 年 1 月至 2020 年 4 月在本院行 PCI 治疗的208 例 STEMI患者的临床资料,根据PCI术后是否发生无复流将其分为正常复流组和无复流组.比较两组患者的临床资料,Cox多因素回归分析影响无复流的危险因素,采用受试者工作特征(ROC)曲线评估再灌注时间、糖化血红蛋白(HbA1c)和 SII对无复流的预测价值.以 SII预测无复流的截断值为分界点,将患者分为 SII 低水平组和 SII高水平组,比较正常复流组和无复流组间、SII低水平组和 SII高水平组间术后 3 年的生存率.[结果]无复流组TIMI等级>2 级患者比例、糖尿病比例高于正常复流组,入门(进入急诊室)至球囊扩张(DTB)、症状发作至球囊扩张(STB)、CK-MB峰值、高密度脂蛋白胆固醇(HDL-C)、餐后血糖、空腹血糖(FPG)和 SII水平高于正常复流组,差异有统计学意义(P<0.05).Cox多因素回归分析显示,STB、DTB、HbA1c 和 SII 为影响无复流的相关因素(P<0.05).ROC曲线分析显示,STB、DTB、HbA1c和 SII对无复流发生均有预测价值,但 SII对无复流发生的预测价值高于 STB、DTB、HbA1c(Z =3.965、4.201、4.062,P =0.018、0.014、0.021).无复流组术后 3 年生存率为 56.3%(27/48),低于复流正常组的 80.6%(129/160),差异有统计学意义(P<0.05).SII 高水平组术后 3 年生存率为 30.8%(20/65),低于 SII低水平组的 84.2%(80/95),差异有统计学意义(P<0.05).[结论]SII可预测 STEMI患者行PCI治疗后无复流的发生情况,并可影响患者的术后生存率.
Predictive Value of Systemic Immune-inflammatory Index for No-reflow after PCI in Patients with Acute ST Segment Elevation Myocardial Infarction
[Objective]To investigate the predictive value of systemic immune-inflammatory index(SII)for no-reflow after percutaneous coronary intervention(PCI)in patients with acute ST segment elevation myocardial in-farction(STEMI).[Methods]The clinical data of 208 STEMI patients who underwent PCI in our hospital from January 2016 to April 2020 were retrospectively analyzed.According to whether no-reflow occurred after PCI,they were divided into normal reflow group and no-reflow group.The general clinical data of the two groups were com-pared.Cox multivariate regression analysis was used to analyze the risk factors of no-reflow.Receiver operating characteristic(ROC)curve was used to evaluate the predictive value of reperfusion time,HbA1c and SII for no-re-flow.According to the cut-off value of SII to predict no-reflow,the patients were divided into SII low-level group and SII high-level group.The 3-year survival rates between normal reflow group and no-reflow group,SII low-lev-el group and SII high-level group were compared.[Results]The proportion of patients with TIMI grade>2 and the proportion of diabetes mellitus in the no-reflow group were higher than those in the normal reflow group,and the levels of STB,DTB,CK-MB peak,HDL,postprandial blood glucose,FPG and SII in the no-reflow group were higher than those in the normal reflow group,with statistically significant differences(P<0.05).Cox multi-variate regression analysis showed that STB,DTB,HbA1c and SII were the relevant factors affecting no-reflow(P<0.05).ROC curve analysis showed that STB,DTB,HbA1c and SII had predictive value for no-reflow,but SII had higher predictive value for no-reflow than STB,DTB and HbA1c(Z= 3.965,4.201,4.062;P =0.018,0.014,0.021).The 3-year survival rate in the no-reflow group was 56.3%(27/48),which was lower than 80.6%(129/160)in the normal reflow group,and the difference was statistically significant(P<0.05).The 3-year sur-vival rate in the SII high-level group was 30.8%(20/65),which was lower than 84.2%(80/95)in the SII low-level group,and the difference was statistically significant(P<0.05).[Conclusion]SII can predict the occurrence of no-reflow after PCI in patients with STEMI,and can affect the postoperative survival rate of patients.

ST Elevation Myocardial Infarction/SUAcute DiseasePercutaneous Coronary Intervention

张莉侠、董锦丽

展开 >

商丘市中心医院,河南 商丘 476000

ST段抬高型心肌梗死/外科学 急性病 经皮冠状动脉介入治疗

2024

医学临床研究
湖南省医学会

医学临床研究

影响因子:0.595
ISSN:1671-7171
年,卷(期):2024.41(3)
  • 15